Viewing Study NCT05645094


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-05-20 @ 3:35 PM
Study NCT ID: NCT05645094
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-12-13
First Post: 2022-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Rectal Carcinoma View
None MSI-High View
Keywords: